Liquid Biopsy for Cancer Detection: Clinical and Epidemiologic Considerations.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34462288.
- Also identified by DOI 10.1158/1078-0432.CCR-21-2426.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Detection of circulating nucleic acids, also referred to as liquid biopsy, has been evaluated for detection of cancer in a variety of settings. We describe important clinical and epidemiologic considerations for liquid biopsy applications in cancer early detection and for monitoring of cancer recurrence.<i>See related article by Jeannot et al., p. 5869</i>.
Medical subject headings
- Cell-Free Nucleic Acids
- Neoplastic Cells, Circulating